HTA Quarterly | Late Summer 2018
By Xcenda |
We examine the world's second largest pharmaceuticals market as Japan shifts from a traditional reimbursement assessment. We look at new therapies for Tardive Dyskinesea. We also review Taiwan's Center for Drug Evaluation on its 10 year anniversary.
Heard on the Street
HTA by the Numbers
HTA Decision Map
Find detailed information on product decisions in Australia, Canada, France, Germany, and the United Kingdom with our HTA Decision Map.

Topics:
Market Access
Commercialization